News

McDonald's Türkiye Introduces the Exciting FRIENDS Meal

McDonald's Türkiye Introduces the Exciting FRIENDS Meal

McDonald's Türkiye Introduces the FRIENDS Meal

McDonald's Türkiye is blending delicious food with beloved pop culture by launching the FRIENDS Meal, inspired by the iconic TV series. This limited-time offering features fan favorites, including the Big Mac and Chicken McNuggets, served with a special twist—Monica's Marinara Sauce. Additionally, the experience is enhanced by unique collectibles inspired by the show that can delight fans of all ages.

Exciting Elements of the FRIENDS Meal

The FRIENDS Meal provides a thrilling dining experience. Choose between a Big Mac or a 6-piece Chicken McNuggets, complemented by crispy fries and a refreshing soft drink. Each meal comes in a special FRIENDS-themed box that houses not only the meal but also one of six iconic collectible characters from the series. To make it even more exciting, the exclusive marinara sauce adds a delicious Italian flair, crafted with fresh tomatoes and herbs.

Collectible Characters in the FRIENDS Meal

Each collectible character represents a memorable moment from the series. You'll find Ross with his pet monkey Marcel, Rachel serving coffee, Monica in the kitchen, and Phoebe with her guitar. Chandler and Joey make an appearance with their quirky duo of a chick and a duck. These collectibles will surely inspire nostalgia and make great conversation starters.

Special Promotions for Fans

McDonald's Türkiye is looking out for its fans. During the first week of the FRIENDS Meal launch, users of the MyMcDonald's app can earn double points on their orders. This is a fantastic opportunity for fans to enjoy their favorite meals while also racking up points towards exclusive FRIENDS merchandise, including apparel, tote bags, and even keychains.

The FRIENDS Coffee Corner Experience

To create a joyful atmosphere, select McDonald's Türkiye locations will now feature a dedicated FRIENDS Coffee Corner. This area is designed for fans to snap photos and connect with friends in a vibrant setting that echoes the show's charm.

Iconic Purple Door Installation

Adding more excitement, McDonald's Türkiye has placed Monica's famous purple door at one of its restaurants in Be?ikta?, becoming a must-see attraction. Visitors can ring the doorbell, and in true FRIENDS fashion, they will hear a nostalgic McDonald's jingle, making for an unforgettable moment. Additionally, a FRIENDS-themed light-up wall serves as a bright backdrop perfect for shareable photos.

About McDonald's Türkiye

McDonald's has long been a staple in the food industry. Ranking among the world's most valuable brands, it opened its first location in Türkiye in 1986. Today, McDonald's Türkiye boasts over 300 locations with a dedicated team of more than 10,000 employees. Most impressively, 98% of their offerings are sourced from local suppliers, emphasizing the brand's commitment to supporting the local economy.

Contact for more information: Kaan Kiri?çio?lu; +90 533 261 91 55

Frequently Asked Questions

What is included in the FRIENDS Meal?

The FRIENDS Meal includes a choice of Big Mac or Chicken McNuggets, fries, a drink, and a collectible character from the FRIENDS series.

Is the FRIENDS Meal available nationwide?

Yes, the FRIENDS Meal is available at participating McDonald's Türkiye locations while supplies last.

Can I earn points for my purchase through the MyMcDonald's app?

Absolutely! During the first week of the FRIENDS Meal launch, app users can earn double points on their orders.

What collectible characters can I expect with the FRIENDS Meal?

You can find characters representing memorable moments from the show, such as Ross, Rachel, Monica, Phoebe, Chandler, and Joey.

What special promotions are offered during the FRIENDS Meal launch?

McDonald's Türkiye offers dual point collection in the MyMcDonald's app and exclusive FRIENDS merchandise redeemable with collected points.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading